Sarchi Christopher 4

What Happened Christopher Sarchi, Chief Commercial Officer of Replimune Group, sold 12,000 shares on June 1, 2026. The weighted-average sale price was $9.24 per share, for total proceeds of approximately $110,880. The shares were sold in multiple transactions at prices ranging from $9.15 to $9.62 per share. This was a sale (liquidity event), which is often routine rather than a direct signal about company prospects.

Key Details

• Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (appears timely).
• Sale type/code: S (open-market or private sale); reported as multiple trades.
• Prices: weighted average $9.24; range $9.15–$9.62 per share.
• Proceeds: ~$110,880 for 12,000 shares.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: (F1) Sales were made pursuant to a Rule 10b5‑1 trading plan adopted December 15, 2025. (F2) Weighted average price shown; the filer can provide the number of shares sold at each price on request.

Context Sales executed under a pre-established 10b5‑1 plan are common for insiders to manage scheduled liquidity and are generally treated as routine. Such sales do not, by themselves, indicate insider sentiment about the company’s future performance.